SYK
史賽克 STRYKER CORP
-4.34 (-1.52%)280.42USD547K成交股數108B市值26.6本益比(近四季)4.2股價營收比+9.4%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 6.6B+9% | 6.0B+3% | 7.2B+11% | 6.1B+10% | 6.0B+11% | 5.9B+12% | 6.4B+11% | 5.5B+12% | 5.4B | 5.2B | 5.8B | 4.9B |
| 營業成本 | 2.1B | 2.2B | – | 2.2B | 2.2B | 2.1B | – | 2.0B | 2.0B | 1.9B | – | 1.8B |
| 毛利 | 4.5B+17% | 3.8B+2% | 4.6B+11% | 3.9B+10% | 3.8B+12% | 3.7B+12% | 4.2B+13% | 3.5B+11% | 3.4B | 3.3B | 3.7B | 3.2B |
| 毛利率 | 68.3% | 63.3% | 64.5% | 63.6% | 63.8% | 63.8% | 64.9% | 64.0% | 63.0% | 63.6% | 63.7% | 64.3% |
| 研發費用 | 434M | 413M | – | 410M | 407M | 405M | – | 377M | 363M | 368M | – | 353M |
| 銷售管理費用 | 2.2B | 2.3B | – | 2.0B | 2.1B | 2.3B | – | 1.9B | 1.8B | 1.8B | – | 1.7B |
| 營業利益 | 1.7B+49% | 936M+12% | – | 1.1B+5% | 1.1B+6% | 837M-14% | – | 1.1B+17% | 1.1B | 972M | – | 931M |
| 營業利益率 | 25.2% | 15.5% | – | 18.7% | 18.5% | 14.3% | – | 19.7% | 19.4% | 18.5% | – | 19.0% |
| 稅後淨利 | 1.3B+44% | 745M+14% | 849M+55% | 859M+3% | 884M+7% | 654M-17% | 546M-52% | 834M+21% | 825M | 788M | 1.1B | 692M |
| 淨利率 | 19.4% | 12.4% | 11.8% | 14.2% | 14.7% | 11.1% | 8.5% | 15.2% | 15.2% | 15.0% | 19.7% | 14.1% |
| 稀釋 EPS | 3.30+44% | 1.93+14% | 2.20+56% | 2.22+3% | 2.29+7% | 1.69-18% | 1.41-53% | 2.16+20% | 2.14 | 2.05 | 2.98 | 1.80 |
| 稀釋股數 | 386M | 387M | – | 387M | 386M | 386M | – | 386M | 385M | 385M | – | 384M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.4B | 2.9B | 4.0B | 3.3B | 2.4B | 2.3B | 3.7B | 3.9B | 1.9B | 2.3B | 3.0B | 1.9B |
| 應收帳款 | 3.7B | 3.6B | 4.0B | 3.6B | 3.9B | 4.0B | 4.0B | 3.7B | 3.6B | 3.5B | 3.8B | 3.3B |
| 存貨 | 5.5B | 5.4B | 5.3B | 5.4B | 5.3B | 5.1B | 4.8B | 5.3B | 5.0B | 5.0B | 4.8B | 4.9B |
| 總資產 | 47.9B | 46.3B | 47.8B | 47.1B | 46.3B | 46.0B | 43.0B | 43.8B | 39.1B | 39.4B | 39.9B | 38.0B |
| 有息負債 | 14.2B | 14.2B | 14.9B | 14.8B | 14.8B | 14.4B | 12.2B | 13.3B | 10.1B | 10.8B | 10.9B | 10.4B |
| 總負債 | 23.9B | 23.3B | 25.4B | 25.3B | 25.1B | 25.1B | 22.3B | 23.7B | 19.4B | 20.2B | 21.3B | 20.1B |
| 股東權益 | 24.0B | 23.0B | 22.4B | 21.8B | 21.2B | 20.9B | 20.6B | 20.1B | 19.8B | 19.2B | 18.6B | 17.9B |
| 負債比 | 50.0% | 50.4% | 53.1% | 53.7% | 54.3% | 54.5% | 52.0% | 54.0% | 49.5% | 51.3% | 53.4% | 52.9% |
| 淨現金(現金 − 有息負債) | −10.8B | −11.3B | −10.8B | −11.6B | −12.5B | −12.1B | −8.5B | −9.5B | −8.3B | −8.5B | −7.9B | −8.5B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 581M+132% | – | – | – | 250M+23% | – | – | – | 204M | – | – |
| 資本支出 | – | 166M | – | – | – | 123M | – | – | – | 167M | – | – |
| 自由現金流 | – | 415M+227% | – | – | – | 127M+243% | – | – | – | 37.0M | – | – |
| 折舊攤銷 | 404M | 397M | – | 404M | 387M | 361M | – | 371M | 354M | 355M | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 337M | – | – | – | 320M | – | – | – | 304M | – | – |
| 自由現金流率 | – | 6.9% | – | – | – | 2.2% | – | – | – | 0.7% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 34.6B
| Med Surg And Neurotechnology | 13.7B | 39.6% | +16.5% |
|---|---|---|---|
| Orthopaedics | 11.4B | 33.0% | +5.4% |
| Orthopaedics And Spine | 9.5B | 27.4% | +4.3% |
地區2025 年度 · 25.1B
| 美國 | 19.0B | 75.7% | +12.2% |
|---|---|---|---|
| 歐洲中東非洲 | 3.2B | 12.7% | +9.8% |
| 亞太 | 2.2B | 8.6% | +7.1% |
| Other Foreign Countries | 765M | 3.0% | +4.1% |
| 美國以外 小計 | 6.1B | 24.3% | +8.1% |
產品／服務2025 年度 · 2.9B
| Orthopaedic Instruments | 2.1B | 72.1% | +10.1% |
|---|---|---|---|
| Other Orthopedics | 660M | 22.6% | +17.9% |
| Enabling Technologies | 155M | 5.3% | +2.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 25.1B | +11.2% | 3.2B | 12.9% | 8.40 | 4.3B |
| FY2024 | 22.6B | +10.2% | 3.0B | 13.2% | 7.76 | 3.5B |
| FY2023 | 20.5B | +11.1% | 3.2B | 15.4% | 8.25 | 3.1B |
| FY2022 | 18.4B | +7.8% | 2.4B | 12.8% | 6.17 | 2.0B |
| FY2021 | 17.1B | +19.2% | 2.0B | 11.7% | 5.21 | 2.7B |
| FY2020 | 14.4B | -3.6% | 1.6B | 11.1% | 4.20 | 2.8B |
| FY2019 | 14.9B | +9.4% | 2.1B | 14.0% | 5.48 | 1.5B |
| FY2018 | 13.6B | – | 3.6B | 26.1% | 9.34 | 2.0B |